Long-Term Assets: The sum of all assets classified as non-current.
Basilea Pharmaceutica AG (BPMUF) had Long-Term Assets of $38.04M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$263.61M |
|
$4.23M |
|
|
Long-Term Assets |
$38.04M |
$301.65M |
|
$41.69M |
|
$99.38M |
|
$134.92M |
|
$176.61M |
|
$125.05M |
|
$124.64M |
|
$125.05M |
|
12.28M |
|
| Cash Flow Statement Financials | |
$27.95M |
|
$-0.50M |
|
$-17.54M |
|
$150.99M |
|
$160.88M |
|
$9.89M |
|
$3.43M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|